ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 152 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 1.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $5,106,000 | +26.1% | 152,428 | +0.2% | 0.18% | +20.7% |
| Q3 2016 | $4,050,000 | +11.4% | 152,190 | -7.7% | 0.15% | +8.7% |
| Q2 2016 | $3,635,000 | +5.1% | 164,851 | +40.0% | 0.14% | +16.9% |
| Q1 2016 | $3,460,000 | +4.6% | 117,791 | +17.6% | 0.12% | +14.6% |
| Q4 2015 | $3,307,000 | -3.1% | 100,151 | +6.0% | 0.10% | 0.0% |
| Q3 2015 | $3,414,000 | -9.2% | 94,458 | +13.0% | 0.10% | +7.3% |
| Q2 2015 | $3,761,000 | – | 83,605 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 862,848 | $42,556,000 | 14.73% |
| Fairmount Funds Management LLC | 171,147 | $8,441,000 | 3.56% |
| ARMISTICE CAPITAL, LLC | 1,648,000 | $81,279,000 | 1.87% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $98,393,000 | 0.49% |
| Jackson Creek Investment Advisors LLC | 21,409 | $1,056,000 | 0.37% |
| Hennion & Walsh Asset Management, Inc. | 113,940 | $5,620,000 | 0.34% |
| Virtus ETF Advisers LLC | 14,721 | $726,000 | 0.31% |
| Granahan Investment Management | 193,416 | $9,539,000 | 0.20% |
| Yorktown Management & Research Co Inc | 4,500 | $222,000 | 0.18% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 242,257 | $11,948,000 | 0.09% |